摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-二氨基-5,6,7,8-四氢蝶啶 | 15891-13-1

中文名称
2,4-二氨基-5,6,7,8-四氢蝶啶
中文别名
——
英文名称
2,4-diamino-5,6,7,8-tetrahydropteridine
英文别名
5,6,7,8-tetrahydro-pteridine-2,4-diamine;5,6,7,8-tetrahydro-pteridine-2,4-diyldiamine;5,6,7,8-Tetrahydro-pteridin-2,4-diyldiamin;2,4-Diamino-5,6,7,8-tetrahydro-pteridin;Pteridine, 2,4-diamino-5,6,7,8-tetrahydro-;5,6,7,8-tetrahydropteridine-2,4-diamine
2,4-二氨基-5,6,7,8-四氢蝶啶化学式
CAS
15891-13-1
化学式
C6H10N6
mdl
——
分子量
166.186
InChiKey
WUAKSYDPKFNCMY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    531.4±60.0 °C(Predicted)
  • 密度:
    1.392±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    102
  • 氢给体数:
    4
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • Pteridines. Part C. Structure and nonenzymatic synthesis of aurodrosopterin
    作者:Jeongbin Yim、Sujeong Kim、Gunter Walcher、Wolfgang Pfleiderer
    DOI:10.1002/hlca.19930760516
    日期:1993.8.11
    The nonenzymatic synthesis of aurodrosopterin (5) from 6-acetyl-2-amino-3, 7, 8, 9-tetrahydro-4H-pyrimido-[4,5-b][1,4]diazepin-4-one (3) and 7,8-dihydrolumazine (4) at pH 3 (HCl) was performed. The identity of the synthesized compound with the natural eye pigment isolated from drosophila heads was confirmed by thin-layer chromatography on cellulose and by comparisons of the 1H-NMR and UV/VIS spectra
    aurodrosopterin(的非酶合成5)由6-乙酰基-2-基-3-,7,8,9四氢-4- ħ -pyrimido- [4,5- b ] [1,4]二氮杂-4-酮(3)和在pH 3(HCl)下进行7,8-二氢鲁嗪(4)。通过在纤维素上的薄层色谱法以及通过1 H-NMR和UV / VIS光谱的比较,证实了合成的化合物与从果蝇头部分离出的天然眼色素的身份。由3的非酶促合成新蝶呤类红色素也进行了2,4-二基-7,8-二氢蝶啶,但不能确定其身份。这种色素被称为基drosopterin,在489 nm处有一个吸收峰,与新drosopterin的吸收峰非常接近。
  • Inhibition of Neuronal Nitric Oxide Synthase by 4-Amino Pteridine Derivatives:  Structure−Activity Relationship of Antagonists of (6<i>R</i>)-5,6,7,8-Tetrahydrobiopterin Cofactor
    作者:Lothar G. Fröhlich、Peter Kotsonis、Hermann Traub、Shahriyar Taghavi-Moghadam、Najim Al-Masoudi、Heinrich Hofmann、Hartmut Strobel、Hans Matter、Wolfgang Pfleiderer、Harald H. H. W. Schmidt
    DOI:10.1021/jm981129a
    日期:1999.10.1
    The family of nitric oxide synthases (NOS) catalyzes the conversion of L-arginine to L-citrulline and nitric oxide (NO), an important cellular messenger molecule which has been implicated in the pathophysiology of septic shock and inflammatory and neurodegenerative disease states. NOS can be maximally activated by the ubiquitous cofactor, (6R)-5,6,7,8-tetrahydrobiopterin (H(4)Bip), and antagonists of H(4)Bip may be of therapeutic importance to inhibit pathologically high NO formation. The 4-amino substituted analogue of H(4)Bip was reported to be a potent NOS inhibit-or. Therefore, we developed a series of novel 4-amino pteridine derivatives, antipterins, to pharmacologically target the neuronal isoform of nitric oxide synthase (NOS-I). To functionally characterize the pterin/anti-pterin interaction and establish a structure-activity relationship (SAR), we systematically altered the substituents in the 2-, 4-, 5-, 6-, and 7-position of the pteridine nucleus. Varying the substitution pattern in the 2-, 5-, and 7-position resulted in no significant inhibitory effect on enzyme activity. In contrast, bulky substituents in the B-position, such as phenyl, markedly increased the inhibitory potency of the reduced 4-amino-5,6,7,8-tetrahydropteridines, possibly as a consequence of hydrophobic interactions within NOS-I. However, this was not the case for the aromatic 4-amino pteridines. Interestingly, chemical modification of the 4-amino substituent by dialkyl/diaralkylation together with 6-arylation of the aromatic 2,4-diamino pteridine resulted in potent and efficacious inhibitors of NOS-I, suggesting possible hydrophilic and hydrophobic interactions within NOS-I. This SAR agrees with (a) the recently published crystal structure of the oxygenase domain of the inducible NOS isoform (NOS-II) and (b) the comparative molecular field analysis of selected NOS-I inhibitors, which resulted in a 3D-QSAR model of the pterin binding site interactions. Further optimization should be possible when the full length structure of NOS-I becomes available.
  • Konrad; Pfleiderer, Chemische Berichte, 1970, vol. 103, p. 722,729
    作者:Konrad、Pfleiderer
    DOI:——
    日期:——
查看更多

同类化合物

黄素酰色氨酸 高蝶酸 骏河毒素 酵母粉 诺米林酸17-β-D-吡喃葡萄糖苷 蝶酸 蝶啶3-氧化物 蝶啶-6-基-甲醇 蝶啶-4,6-二胺 蝶啶-2,4-二胺 蝶呤-6-羧酸 苯癸酸,2-羟基-3,4-二甲氧基-6-甲基 苯并[g]蝶啶-4a(2H)-基,5-乙基-3,4,5,10-四氢-3,7,8,10-四甲基-2,4-二羰基- 苯并[g]蝶啶-2,4(1H,3H)-二酮,5-乙酰基-5,10-二氢-1,3-二甲基- 苯并[g]蝶啶-2,4(1H,3H)-二酮,5,10-二氢-7,8-二甲基- 苯并[g]蝶啶-2,4(1H,3H)-二酮,1,7,8-三甲基- 羧甲基黄素 羟基-2-吡啶酮 维生素 B2 维他命 B2 硫酸氢3-(6,7-二氯-2,4-二羰基-3,4-二氢苯并[g]蝶啶-10(2H)-基)-N-乙基-N-(2-羟基乙基)丙烷-1-铵 硫酸氢2-(7,8-二氯-2,4-二羰基-3,4-二氢苯并[g]蝶啶-10(2H)-基)-N,N-二甲基乙铵 甲氨蝶呤钠 甲氨蝶呤杂质1 生物蝶呤-d3 生物喋呤中间体 环己烯,3-氟-4-(甲硫基)-,反-(9CI) 玫瑰黄色素 溴化氢溴化1-(2-氨基乙基)-3-甲基-4-[(Z)-2-萘-1-基乙烯基]吡啶正离子 氯化3-(7-氯-2,4-二羰基-3,4-二氢苯并[g]蝶啶-10(2H)-基)-N,N-二甲基丙烷-1-铵 氨蝶呤钠 氨苯蝶啶 氨甲酸,[(1S)-2-羟基-1-甲基丙基]-,1,1-二甲基乙基酯(9CI) 氨甲蝶呤 氨基蝶呤 核黄素还原 核黄素杂质Q 核黄素5'-硫酸盐 核黄素3′,4′-二磷酸酯 核黄素-4'-磷酸 核黄素-3'-磷酸盐 核黄素,2',3',4',5'-四乙酸酯 核黄素 5'-丁酸酯 核黄素 无色喋呤 异黄蝶呤 己二酸,2-[[4-[[(2-氨基-1,4,5,6,7,8-六氢-4-羰基-6-蝶啶基)甲基]氨基]苯甲酰]氨基]- 左亚叶酸钙杂质 左亚叶酸钙 四氢蝶酰五谷氨酸酯